Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MBX Biosciences, Inc. - Common Stock (NQ:MBX)

31.96 -1.43 (-4.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 448,136
Open 33.33
Bid (Size) 28.00 (100)
Ask (Size) 33.29 (100)
Prev. Close 33.39
Today's Range 30.82 - 33.33
52wk Range 8.750 - 44.89
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase ↗
MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several clinical phases. 
Via The Motley Fool
News headline image
MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know ↗
Focused on precision therapies for endocrine disorders, this biotech firm reported a notable insider buy amid a year of sharp stock gains. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+4.6%
+4.6%
1 Month
+10.4%
+10.4%
3 Month
-15.6%
-15.6%
6 Month
+88.0%
+88.0%
1 Year
+244.8%
+244.8%

More News

Read More
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
Via MarketMinute
Topics ETFs Economy Intellectual Property
MBX Stock Soars Pre-Market After Investigational Hypoparathyroidism Drug Yields Positive Results In Study ↗
Via Stocktwits
News headline image
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
Via Benzinga
News headline image
Which stocks have an unusual volume on Thursday? ↗
Via Chartmill
News headline image
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
Topics Stocks
News headline image
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
News headline image
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade—Kenvue, Micron Tech, Nvidia In Focus ↗
Via Benzinga
Topics Stocks
News headline image
AutoZone, Micron Technology And 3 Stocks To Watch Heading Into Tuesday ↗
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-09-22: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Gold Gains Over 1%; Quantum Computing Shares Plunge ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
PROS Holdings, MBX Biosciences, Metsera, Anywhere Real Estate And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Dow Falls Over 100 Points; Chicago Fed National Activity Index Rises In August ↗
Via Benzinga
Topics Economy Stocks
News headline image
MBX Biosciences Catapults 125%, Hitting A Nine-Month High, On Thyroid Drug Promise ↗
Via Investor's Business Daily
News headline image
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
MBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism Study ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is MBX Biosciences, Inc. - Common Stock publicly traded?
Yes, MBX Biosciences, Inc. - Common Stock is publicly traded.
What exchange does MBX Biosciences, Inc. - Common Stock trade on?
MBX Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MBX Biosciences, Inc. - Common Stock?
The ticker symbol for MBX Biosciences, Inc. - Common Stock is MBX on the Nasdaq Stock Market
What is the current price of MBX Biosciences, Inc. - Common Stock?
The current price of MBX Biosciences, Inc. - Common Stock is 31.96
When was MBX Biosciences, Inc. - Common Stock last traded?
The last trade of MBX Biosciences, Inc. - Common Stock was at 04/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.